Wapnick Pamela
- SEC CIK
- 0001995657
In the past year, 5 open-market sale filings worth $14.1K and no purchases.
Current role at each company
- MGX Metagenomi Therapeutics, Inc.Chief Financial Officeras of Sep 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $14.1K
- 5 filings
- Net
- −$14.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wapnick Pamela as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 (view filing)3:34 PM ET | Sep 8 | 2 days | Wapnick PamelaChief Financial Officer | SSale | −1.91K | $1.16 | −$2.21K | −0.9%206.6K after | |
| Jun 10, 2026 (view filing) | Jun 5 | 5 daysLate | Wapnick PamelaChief Financial Officer | SSale | −2.88K | $1.30 | −$3.75K | −1.4%208.5K after | |
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Wapnick PamelaChief Financial Officer | SSale | −1.58K | $1.60 | −$2.53K | −0.8%187.4K after | |
| Dec 8, 2025 (view filing) | Dec 5 | 3 days | Wapnick PamelaChief Financial Officer | SSale | −1.58K | $1.77 | −$2.79K | −0.8%189.0K after | |
| Dec 1, 2025 (view filing) | Sep 5 | 87 daysLate | Wapnick PamelaChief Financial Officer | SSale | −1.58K | $1.81 | −$2.85K | −2.2%70.5K after | |
| Jun 9, 2025 (view filing) | Jun 6 | 3 days | Wapnick PamelaChief Financial Officer | SSale | −1.58K | $1.75 | −$2.76K | −2.1%72.1K after | |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Wapnick PamelaChief Financial Officer | SSale | −1.81K | $1.87 | −$3.38K | −2.9%59.7K after | |
| Dec 6, 2024 (view filing) | Dec 5 | 1 day | Wapnick PamelaChief Financial Officer | SSale | −1.56K | $1.86 | −$2.90K | −2.5%61.5K after | |
| Sep 6, 2024 (view filing) | Sep 5 | 1 day | Wapnick PamelaChief Financial Officer | SSale | −6.26K | $2.88 | −$18.0K | −9.0%63.1K after |